Uncovering Functional Folate Deficiency: The Clinical Value of FRAT®
When folate can’t reach the brain, symptoms can linger even when standard labs look “normal.” FRAT® helps bridge that gap. This physician-ordered blood test, the clinically validated folate receptor autoantibody test, is designed to support evaluation when disrupted folate transport is suspected in sensitive tissues like the brain and placenta.
Developed at SUNY Downstate Medical Center by Dr. Edward Quadros, FRAT® is grounded in peer-reviewed research and used by clinicians worldwide.
What is the Folate Receptor Autoantibody Test?
The Folate Receptor Autoantibody Test (FRAT®) is a specialized blood test that measures specific folate receptor autoantibodies that can disrupt the body’s ability to move folate into essential tissues. These antibodies target the folate receptor alpha (FRα), a key protein responsible for folate transport across the placenta and into the brain and other tissues that rely on healthy folate levels.
What FRAT® Detects
FRAT® identifies two main types of autoantibodies that can affect folate movement:
- Blocking antibodies that prevent folate from binding to the folate receptor.
- Binding antibodies that attach to and disturb receptor activity.
The presence of these folate receptor autoantibodies can be associated with conditions such as cerebral folate deficiency, certain developmental or neurological symptoms, and patterns observed in autism spectrum disorder.
Why FRAT® Matters: Detecting Functional Folate Deficiency Missed by Routine Tests
FRAT® focuses on what standard serum folate cannot show: whether folate receptor autoantibodies are disrupting folate transport into the tissues that rely on it most.
- Why folate is essential: Folate supports energy production, brain and nerve health, and healthy fetal growth. It plays a vital role in DNA repair, neurotransmitter balance, and cell development.
- When folate receptor autoantibodies block the folate receptor, folate can’t reach the brain and placenta as it should. This creates a “functional” folate deficiency.
- Why that matters: FRAT® is the only test that detects this type of immune interference.
- When it’s important to test: Functional folate loss may contribute to developmental delays, learning or attention challenges, seizures, or mood changes. In some children with autism, this mechanism may affect speech, behavior, or social interaction.
FRAT® matters because it looks beyond surface-level numbers to show whether the body is actually getting folate where it’s needed most.
Conditions Linked to Folate Receptor (FRα) Autoantibodies
Understanding what the folate receptor autoantibody test (FRAT®) can reveal helps clinicians identify functional folate deficiency that routine serum tests may miss.
- Cerebral Folate Deficiency (CFD): Low folate activity within the central nervous system despite normal blood levels. FRAT® helps identify folate receptor autoantibodies that may impair folate transport, contributing to cerebral folate deficiency or cerebral folate deficiency syndrome (CFD).
- Autism Spectrum Disorder (ASD): FRAT® can clarify whether folate receptor involvement is present, a context for challenges in verbal communication, learning, or social interaction, and for further evaluation of targeted support.
- Mood and Thought Disorders: Findings in depression and schizophrenia may relate to disrupted methylation and folate metabolism. Identifying folate receptor alpha autoantibodies provides insight that informs next steps.
- Pregnancy & Reproductive Health: When folate receptor interference affects placental transfer, clinicians consider risks such as neural tube defects or recurrent pregnancy loss. FRAT® assists in recognizing immune-related barriers to folate delivery that are not visible on a standard blood test.
Treatment Options After Getting FRAT® Results
FRAT® results help clarify whether folate receptor autoantibodies are limiting folate transport at the folate receptor, guiding next steps in a personalized, evidence-informed care plan.
- Guiding individualized care: Test results, combined with medical history and symptoms, help determine the most appropriate treatment approach.
- Folinic acid (leucovorin calcium): Folinic acid can bypass receptor blockage, helping restore normal folate transport.
- Evidence in children with autism: Addressing folate receptor alpha interference has been linked to improvements in attention, learning, and verbal communication.
- Dietary and lifestyle adjustments: A clinician may also recommend making dietary adjustments, such as limiting cow’s milk products, which may help reduce certain folate receptor autoantibodies.
How to Get Tested for FRAT®
Getting the folate receptor autoantibody test (FRAT®) is straightforward and coordinated with a care team so results translate into clear next steps.
1. Request the test
Ask a physician to order the folate receptor autoantibody test or use the clinic’s online request.
2. Complete a simple blood draw
A standard blood test (serum sample) is collected—typically no fasting required. The process is quick and similar to other routine labs.
3. Laboratory analysis
A sample is analyzed to detect folate receptor autoantibodies that may interfere with folate transport at the folate receptor. Results typically include antibody presence and levels.
4. Review results with a clinician
A provider will interpret findings alongside medical history and current concerns and discuss treatment options tailored to specific needs.
FRAT® for Autism
When folate receptor autoantibodies (FRA) block folate transport into the central nervous system (CNS), reduced folate availability may contribute to features observed in autism spectrum disorder (ASD).
Research, including Frye et al., 2018, has shown that addressing FRA-related folate disruption with leucovorin (folinic acid) therapy can support improvements in language, attention, and social interaction.
Early FRAT® helps identify FRA-related folate issues, allowing clinicians to consider timely interventions that may promote neurodevelopmental progress.
Support comprehensive evaluation in children diagnosed with ASD. Discuss FRAT® with a pediatrician or request a test kit.
FRAT® for Pregnancy
FRα autoimmunity can impair placental folate transport, potentially increasing the risk of neural tube defects, miscarriage, or fertility challenges.
FRAT® complements standard prenatal screenings by identifying folate receptor autoantibodies that routine blood tests may miss—helping expectant mothers access timely, targeted folate support and dietary adjustments when needed.
Gain a clearer view of folate health during pregnancy. Request FRAT® at your next OB visit.
FRAT® for Mental Health
Folate supports methylation and monoamine synthesis, processes vital for mood regulation and neurological balance. When folate receptor autoantibodies (FRA) disrupt folate transport, they may contribute to treatment-resistant depression, bipolar disorder, or schizophrenia.
FRAT® helps determine whether active folate therapy is warranted by distinguishing nutritional deficiency from autoimmune interference.
Physicians can order and interpret FRAT® results to guide evidence-based treatment decisions.
Get the Folate Receptor Autoantibody Test at Internal Healing and Wellness MD
Gain clear, clinically relevant insight into folate transport and next steps in care.
FRAT® price: $499.00
- Physician-ordered testing with coordinated follow-up
- Simple serum blood draw; no routine fasting required
- Detection of blocking and binding folate receptor autoantibodies
- Results reviewed by a clinician to guide appropriate treatment planning
Begin an evidence-informed evaluation today.
Research & Evidence for Folate Receptor Autoantibody Testing
- Translational foundation: Decades of work on the folate receptor (FRα) and folate transport across the blood–brain barrier and placenta link folate receptor autoantibodies to low central folate activity and cerebral folate deficiency.
- Autism-spectrum findings: Studies in children with autism report that, when folate receptor autoantibodies are present, clinician-guided folinic acid (leucovorin calcium) support has been associated with improvements in areas such as attention or verbal communication.
- Dietary signals: Research suggests some patients may show lower antibody titers with cow’s-milk–free approaches, aligning with the molecular mimicry hypothesis; any dietary adjustments should be clinician-directed.
- Ongoing trials: Registered studies continue to investigate FRα-targeted strategies and outcomes, reflecting active innovation in folate receptor autoimmunity research.
These findings reinforce FRAT® as a validated adjunct to standard evaluation—helping determine when a folate receptor autoantibody test adds value beyond routine serum measures.
Frequently Asked Questions
The folate receptor autoantibody test (FRAT®) measures specific antibodies that can block or bind to the folate receptor alpha (FRα), the protein responsible for moving folate into the brain and placenta. Detecting these antibodies helps determine whether folate transport is being disrupted.
FRAT® may be recommended for individuals with unexplained neurological symptoms, developmental delays, or treatment-resistant depression, and for children diagnosed with autism spectrum disorder. It can also be useful in evaluating fertility concerns or recurrent pregnancy loss linked to impaired folate metabolism.
Yes. In cerebral folate deficiency, folate receptor autoantibodies prevent folate from crossing the blood–brain barrier, leading to low levels in the central nervous system even when blood folate appears normal. FRAT® helps identify this “functional” deficiency that standard blood tests can miss.
In some children with autism, folate receptor autoantibodies may contribute to reduced folate activity in the brain. Identifying these antibodies through FRAT® allows clinicians to explore targeted folate restoration strategies under medical supervision.
If FRAT® detects antibodies, a physician will review results alongside medical history and discuss possible treatment options. This may include folinic acid (leucovorin calcium) supplementation or individualized dietary adjustments to support healthy folate use.
Take the Next Step Today
Early identification of folate receptor autoantibodies can make a critical difference in diagnosis and care. Support informed evaluation and personalized treatment planning guided by a qualified physician. Schedule a FRAT® consultation now.
Relevant Studies and Resources
FRAT® identifies two main types of autoantibodies that can affect folate movement:
Stay Informed on the Latest Health & Wellness Tips
Subscribe to our newsletter and receive regular updates on integrative approaches to health, the latest research, and wellness tips from our experts.
Start your journey to better health today!
Enter your email address below to stay connected:
Book Your Consultation Today
During your first 60-minute functional televisit, we will try to figure out what’s causing your current health problems. Contact us today at Internal Healing and Wellness MD in the Houston area and The Woodlands, we will make sure to provide you with a personalized functional medicine-based treatment plan so that you can begin working towards your goal of a better, healthier life.
Testimonials
Our 5-Star Reviews
Discover why our clients rave about our services in our review section. Hear their stories, read their feedback, and see why our services are making a real difference.
Start Your Holistic Wellness Journey Today
In search of a functional medicine doctor in The Woodlands? Dr. Khan and his experienced team are at your service, ready to help you make life-changing strides toward your health and wellness goals.
Contact Info
Our Location
255 Ed English Dr
Suite A
Shenandoah, TX 77385
Our Schedule
Monday - Friday : 8 AM – 5 PM
Get In Touch
For functional medicine inquiries, contact our experienced functional medicine doctors. We take a holistic approach to improving health and well-being.